Study of Nutritional Supplement Shakes in People About to Receive Their Debulking Surgery for Ovarian Cancer
Launched by MEMORIAL SLOAN KETTERING CANCER CENTER · May 17, 2019
Trial Information
Current as of May 07, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of nutritional supplement shakes for women who are about to have surgery to remove ovarian cancer. The goal is to see if a program that provides these shakes before surgery can help support the patients' nutrition and overall health during this important time. The study is currently active, but they are not recruiting new participants at the moment.
To be eligible for this study, participants need to be at least 18 years old and scheduled for a specific type of surgery called primary debulking surgery for ovarian, fallopian tube, or primary peritoneal cancer. They must also have enough time before their surgery to start the nutritional shakes, with the last shake taken one to two days before the operation. However, women who have had certain treatments like chemotherapy, have diabetes, or have specific allergies are not able to participate. If someone joins the study, they can expect to receive these nutritional shakes as part of their care leading up to surgery, which could help improve their health during this critical period.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18
- • Scheduled to undergo primary surgical debulking of ovarian, fallopian tube and primary peritoneal cancer
- • Have a sufficient preoperative window during which the intervention can occur, with the last day of supplementation at least one and no more than two days prior to surgery; scheduling of the procedure should not be delayed due to participation in this investigation
- Exclusion Criteria:
- • Have received neoadjuvant chemotherapy
- • Debulking surgery scheduled less than 8 days from initial visit
- • Are scheduled for a minimally invasive procedure
- • Unable to tolerate oral intake or have gastrointestinal issues that would prevent or prohibit oral supplement consumption
- • Have diabetes mellitus
- • Have allergies to the Ensure Surgery Immunonutrition Shake supplement
- • Have galactosemia
About Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center (MSKCC) is a world-renowned institution dedicated to cancer treatment, research, and education. As a leading clinical trial sponsor, MSKCC focuses on advancing innovative cancer therapies through rigorous scientific investigation and collaboration. The center's multidisciplinary team of experts employs cutting-edge methodologies to design and conduct trials that aim to improve patient outcomes and enhance understanding of cancer biology. With a commitment to translating research findings into clinical practice, MSKCC plays a pivotal role in shaping the future of oncology care and ensuring that patients have access to the latest therapeutic advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Miami, Florida, United States
Harrison, New York, United States
Middletown, New Jersey, United States
Montvale, New Jersey, United States
Commack, New York, United States
Harrison, New York, United States
Basking Ridge, New Jersey, United States
Uniondale, New York, United States
Patients applied
Trial Officials
Vance Broach, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials